Dhanuka Agritech Limited has informed the Exchange about Transcript
DHANUKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dhanuka Agritech reported Q4 FY26 revenue of Rs. 483.34 crore, up 9% YoY, with EBITDA at Rs. 124.89 crore and PAT at Rs. 97.77 crore. The strong quarter was boosted by a Rs. 14.5 crore GST refund from the Udhampur unit, which management flagged as a one-time benefit unlikely to repeat. For FY27, the company guides for lower double-digit revenue growth with ~100 bps EBITDA margin decline, citing loss of GST refund (Rs. 29 crore impact) and net economic benefit. Raw material prices have risen 3-5% due to rupee depreciation and geopolitical factors, with ~2% price increases planned for Q1. Dahej manufacturing facility loss was Rs. 13 crore in FY26, with FY27 revenue guidance cut to Rs. 75 crore from earlier Rs. 100 crore estimate. Bayer product revenue of Rs. 27 crore in FY26 is expected to double to Rs. 60 crore in FY27. The company also announced a Rs. 70 crore buyback at Rs. 1,400/share and introduced an ESOP scheme.
The Q4 margins were inflated by a one-time GST refund, and FY27 outlook shows margin pressure from lost tax benefits and rising input costs despite planned price hikes. The Dahej facility continues to be a drag, and the buyback signals management confidence at current valuations.